Novo’s Wegovy becomes first GLP-1 drug approved for MASH
Written by
BioPharma Dive
Published
0
comments
0
min
The FDA clearance sets Novo’s medicine up a market battle with Madrigal Pharmaceuticals’ fast-selling Rezdiffra.